Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Academy of Dermatology
Biotech
Biogen’s litifilimab sparkles in midphase lupus trial
The readout adds to the momentum behind a program barreling toward pivotal data in two forms of the autoimmune disease.
Nick Paul Taylor
Mar 30, 2026 4:45am
Takeda clears path to FDA with phase 3 data on $4B psoriasis bet
Mar 28, 2026 3:00pm
Lilly's lebrikizumab clears eczema in people with skin of color
Mar 11, 2024 9:24am
Novartis lines up another potential indication for BTK inhibitor
Mar 9, 2024 12:00pm
Alumis hits stride as TYK2 inhibitor improves psoriasis in ph. 2
Mar 9, 2024 12:00pm